Electronic Blood Pressure Monitor (BP-204C, BP-204A, BP-215, BP-203C, BP-205A, BP-201C, BP-217, BP-202C, BP-202 BP-205, BP-205B,BP-206)
Shenzhen Brav Electronic Technologies Co., Ltd. · Decision date Oct 1, 2026
What did the FDA decide?
Shenzhen Brav Electronic Technologies Co., Ltd. received a substantially equivalent (SESE) decision for K260470, an Electronic Blood Pressure Monitor listed under model designations BP-204C, BP-204A, BP-215, BP-203C, BP-205A, BP-201C, BP-217, BP-202C, BP-202, BP-205, BP-205B and BP-206. The FDA recorded the decision on 2026-10-01 for a traditional 510(k) received 02/12/2026, classified under regulation 870.1130 with product code DXN in the Cardiovascular specialty and review panel. SESE denotes clearance of the premarket notification, not PMA approval.
The public record does not state which model or component was the subject of any change, nor does it identify a predicate device, so the specific comparison underlying the equivalence finding is unknown. The listing also shows the application was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. No clinical performance data, labeling, or indications for use appear in the available material.
Readers should treat this as a dated regulatory status record only. Any inference about measurement accuracy, intended patient population, or legal scope of clearance would require the underlying FDA decision documents, which were not provided here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260470
- Regulatory pathway
- 510(k) premarket notification
- Product code
- DXN
- Decision code
- SESE
- Decision date
- Oct 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Measurement, Blood-Pressure, Non-Invasive.
- Product code
- DXN
- FDA device class
- 2
FDA decision timeline
K260470 received
Application receipt date recorded by FDA.
K260470 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DXN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| OMRON Healthcare, Inc. | 510(k) clearance | Sep 10, 2026 | FDA | |
| Happy Health, Inc. | 510(k) clearance | Sep 3, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Brav Electronic Technologies Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K260470
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
